Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
- As of  06/15/24, 04:49:49 PM:   42 Insider Transactions.

Sector: Unknown    Industry: Unknown
Prev Close:$0.00  Avg Vol(3m): 0  P/E: 0.00  EPS: 0.00

Email this page to a friend.    Insider Transactions for NULL

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
S 2020-05-11 16:13:06.0 Trillium Therapeutics Inc n/a MORGAN STANLEY 1.5% view
B 2020-02-14 16:00:12.0 Trillium Therapeutics Inc n/a Sio Capital Management 9.81% view
S 2020-02-14 10:31:27.0 Trillium Therapeutics Inc n/a Matrix Capital Management Company 0.0% view
B 2020-02-13 14:25:14.0 Trillium Therapeutics Inc n/a MORGAN STANLEY 6.7% view
B 2020-02-04 17:19:46.0 Trillium Therapeutics Inc n/a Growth Equity Opportunities V 2.59% view
B 2020-02-03 16:31:05.0 Trillium Therapeutics Inc n/a Boxer Capital 5.9% view
B 2020-02-03 16:03:21.0 Trillium Therapeutics Inc n/a Vivo Capital IX 4.9% view
B 2020-01-21 16:52:59.0 Trillium Therapeutics Inc n/a Venrock Healthcare Capital Partners III 9.95% view
S 2020-01-21 11:27:29.0 Trillium Therapeutics Inc n/a Empery Asset Management 4.99% view
B 2019-12-31 16:24:15.0 Trillium Therapeutics Inc n/a MORGAN STANLEY 5.9% view
B 2019-03-04 16:50:24.0 Trillium Therapeutics Inc n/a Empery Asset Management 9.42% view
B 2019-03-04 15:45:01.0 Trillium Therapeutics Inc n/a Growth Equity Opportunities V 2.59% view
S 2019-02-14 16:03:55.0 Trillium Therapeutics Inc n/a Cormorant Asset Management 0.0% view
S 2019-02-14 14:39:03.0 Trillium Therapeutics Inc n/a Matrix Capital Management Company 15.6% view
S 2019-02-12 11:05:58.0 Trillium Therapeutics Inc n/a MORGAN STANLEY 3.5% view
S 2019-01-10 15:39:17.0 Trillium Therapeutics Inc n/a AWM Investment Company 0.0% view
B 2018-12-21 16:03:10.0 Trillium Therapeutics Inc n/a MORGAN STANLEY 5.3% view
B 2018-02-13 16:26:03.0 Trillium Therapeutics Inc n/a BAKER BROS 4.99% view
B 2018-02-13 16:06:01.0 Trillium Therapeutics Inc n/a AWM Investment Company 9.99% view
S 2018-02-06 16:12:22.0 Trillium Therapeutics Inc n/a JANUS CAPITAL MANAGEMENT LLC 0.0% view
B 2017-12-08 13:52:56.0 Trillium Therapeutics Inc n/a Matrix Capital Management Company 16.5% view
B 2017-12-05 15:42:01.0 Trillium Therapeutics Inc n/a Growth Equity Opportunities V 2.59% view
B 2017-06-09 16:37:25.0 Trillium Therapeutics Inc n/a Growth Equity Opportunities V 2.59% view
B 2017-06-05 16:15:52.0 Trillium Therapeutics Inc n/a Cormorant Asset Management 5.66% view
S 2017-02-14 15:04:56.0 Trillium Therapeutics Inc n/a Point72 Asset Management 0.0% view
S 2017-02-13 16:38:51.0 Trillium Therapeutics Inc n/a Mottola Thomas D 2.05% view
S 2017-02-13 14:38:46.0 Trillium Therapeutics Inc n/a JANUS CAPITAL MANAGEMENT LLC 7.3% view
S 2017-02-01 17:03:42.0 Trillium Therapeutics Inc n/a Merlin BioMed Private Equity Advisors 5.46% view
B 2016-02-16 15:41:49.0 Trillium Therapeutics Inc n/a JANUS CAPITAL MANAGEMENT LLC 7.5% view
B 2016-02-16 14:41:11.0 Trillium Therapeutics Inc n/a Mottola Thomas D 8.5% view
B 2016-02-16 13:22:28.0 Trillium Therapeutics Inc n/a Point72 Asset Management 7.5% view
S 2016-02-16 08:18:30.0 Trillium Therapeutics Inc n/a Flynn James E 2.4% view
S 2016-02-12 13:00:55.0 Trillium Therapeutics Inc n/a Opaleye Management Inc 2.7% view
B 2016-02-10 16:32:51.0 Trillium Therapeutics Inc n/a FRANKLIN RESOURCES INC 5.1% view
B 2016-01-29 09:33:48.0 Trillium Therapeutics Inc n/a Stebbins James Henry DeGraff n/a view
B 2015-04-23 16:20:19.0 Trillium Therapeutics Inc n/a Point72 Asset Management 5.6% view
B 2015-04-01 17:31:38.0 Trillium Therapeutics Inc n/a Ridgeback Capital Investments L 6.9% view
B 2015-03-20 11:54:35.0 Trillium Therapeutics Inc n/a Mottola Thomas D 8.4% view
B 2015-02-26 14:08:52.0 Trillium Therapeutics Inc n/a Stebbins James Henry DeGraff n/a view
B 2015-02-23 15:45:33.0 Trillium Therapeutics Inc n/a Opaleye Management Inc 7.8% view
B 2015-02-18 13:45:46.0 Trillium Therapeutics Inc n/a Flynn James E 5.19% view
B 2015-02-17 17:30:27.0 Trillium Therapeutics Inc n/a Merlin BioMed Private Equity Advisors 16.6% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.